United States GABA Receptor Agonist Drug Market Report 2018

Table of Contents

United States GABA Receptor Agonist Drug Market Report 2018
1 GABA Receptor Agonist Drug Overview
1.1 Product Overview and Scope of GABA Receptor Agonist Drug
1.2 Classification of GABA Receptor Agonist Drug by Product Category
1.2.1 United States GABA Receptor Agonist Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States GABA Receptor Agonist Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Bamaluzole
1.2.4 Phenibut
1.2.5 Baclofen
1.2.6 Gaboxadol
1.2.7 Klonopin (clonazepam)
1.2.8 Tiagbine
1.3 United States GABA Receptor Agonist Drug Market by Application/End Users
1.3.1 United States GABA Receptor Agonist Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Psychiatric Disorders and Depression
1.3.4 Alzheimer
1.3.5 Epilepsy and Seizure
1.3.6 Anxiety and Sleep Disorders
1.3.7 Obesity and Alcoholism
1.4 United States GABA Receptor Agonist Drug Market by Region
1.4.1 United States GABA Receptor Agonist Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West GABA Receptor Agonist Drug Status and Prospect (2013-2025)
1.4.3 Southwest GABA Receptor Agonist Drug Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic GABA Receptor Agonist Drug Status and Prospect (2013-2025)
1.4.5 New England GABA Receptor Agonist Drug Status and Prospect (2013-2025)
1.4.6 The South GABA Receptor Agonist Drug Status and Prospect (2013-2025)
1.4.7 The Midwest GABA Receptor Agonist Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of GABA Receptor Agonist Drug (2013-2025)
1.5.1 United States GABA Receptor Agonist Drug Sales and Growth Rate (2013-2025)
1.5.2 United States GABA Receptor Agonist Drug Revenue and Growth Rate (2013-2025)

2 United States GABA Receptor Agonist Drug Market Competition by Players/Suppliers
2.1 United States GABA Receptor Agonist Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States GABA Receptor Agonist Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States GABA Receptor Agonist Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States GABA Receptor Agonist Drug Market Competitive Situation and Trends
2.4.1 United States GABA Receptor Agonist Drug Market Concentration Rate
2.4.2 United States GABA Receptor Agonist Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers GABA Receptor Agonist Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States GABA Receptor Agonist Drug Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States GABA Receptor Agonist Drug Sales and Market Share by Region (2013-2018)
3.2 United States GABA Receptor Agonist Drug Revenue and Market Share by Region (2013-2018)
3.3 United States GABA Receptor Agonist Drug Price by Region (2013-2018)

4 United States GABA Receptor Agonist Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States GABA Receptor Agonist Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States GABA Receptor Agonist Drug Revenue and Market Share by Type (2013-2018)
4.3 United States GABA Receptor Agonist Drug Price by Type (2013-2018)
4.4 United States GABA Receptor Agonist Drug Sales Growth Rate by Type (2013-2018)

5 United States GABA Receptor Agonist Drug Sales (Volume) by Application (2013-2018)
5.1 United States GABA Receptor Agonist Drug Sales and Market Share by Application (2013-2018)
5.2 United States GABA Receptor Agonist Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States GABA Receptor Agonist Drug Players/Suppliers Profiles and Sales Data
6.1 Advicenne
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Athena Drug Delivery Solutions
6.3.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Biocodex
6.4.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Elan Corporation
6.5.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Eli Lilly and Company
6.6.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 H.LundBeck, Merck and Co
6.7.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 NovaDel Pharma
6.9.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Novartis
6.10.2 GABA Receptor Agonist Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 OVATION Pharmaceuticals
6.12 Osmotica Pharmaceutical
6.13 Pfizer
6.14 sanofi-aventis
6.15 VIVUS
6.16 XenoPort

7 GABA Receptor Agonist Drug Manufacturing Cost Analysis
7.1 GABA Receptor Agonist Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 GABA Receptor Agonist Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of GABA Receptor Agonist Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States GABA Receptor Agonist Drug Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States GABA Receptor Agonist Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States GABA Receptor Agonist Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States GABA Receptor Agonist Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States GABA Receptor Agonist Drug Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of GABA Receptor Agonist Drug
Figure United States GABA Receptor Agonist Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Bamaluzole Product Picture
Figure Phenibut Product Picture
Figure Baclofen Product Picture
Figure Gaboxadol Product Picture
Figure Klonopin (clonazepam) Product Picture
Figure Tiagbine Product Picture
Figure United States GABA Receptor Agonist Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of GABA Receptor Agonist Drug by Application in 2017
Figure Attention Deficit Hyperactivity Disorder (ADHD) Examples
Table Key Downstream Customer in Attention Deficit Hyperactivity Disorder (ADHD)
Figure Psychiatric Disorders and Depression Examples
Table Key Downstream Customer in Psychiatric Disorders and Depression
Figure Alzheimer Examples
Table Key Downstream Customer in Alzheimer
Figure Epilepsy and Seizure Examples
Table Key Downstream Customer in Epilepsy and Seizure
Figure Anxiety and Sleep Disorders Examples
Table Key Downstream Customer in Anxiety and Sleep Disorders
Figure Obesity and Alcoholism Examples
Table Key Downstream Customer in Obesity and Alcoholism
Figure United States GABA Receptor Agonist Drug Market Size (Million USD) by Region (2013-2025)
Figure The West GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States GABA Receptor Agonist Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States GABA Receptor Agonist Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States GABA Receptor Agonist Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States GABA Receptor Agonist Drug Sales Share by Players/Suppliers
Figure 2017 United States GABA Receptor Agonist Drug Sales Share by Players/Suppliers
Figure United States GABA Receptor Agonist Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States GABA Receptor Agonist Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States GABA Receptor Agonist Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States GABA Receptor Agonist Drug Revenue Share by Players/Suppliers
Figure 2017 United States GABA Receptor Agonist Drug Revenue Share by Players/Suppliers
Table United States Market GABA Receptor Agonist Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market GABA Receptor Agonist Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States GABA Receptor Agonist Drug Market Share of Top 3 Players/Suppliers
Figure United States GABA Receptor Agonist Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers GABA Receptor Agonist Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers GABA Receptor Agonist Drug Product Category
Table United States GABA Receptor Agonist Drug Sales (K Pcs) by Region (2013-2018)
Table United States GABA Receptor Agonist Drug Sales Share by Region (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Share by Region (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Market Share by Region in 2017
Table United States GABA Receptor Agonist Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States GABA Receptor Agonist Drug Revenue Share by Region (2013-2018)
Figure United States GABA Receptor Agonist Drug Revenue Market Share by Region (2013-2018)
Figure United States GABA Receptor Agonist Drug Revenue Market Share by Region in 2017
Table United States GABA Receptor Agonist Drug Price (USD/Pcs) by Region (2013-2018)
Table United States GABA Receptor Agonist Drug Sales (K Pcs) by Type (2013-2018)
Table United States GABA Receptor Agonist Drug Sales Share by Type (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Share by Type (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Market Share by Type in 2017
Table United States GABA Receptor Agonist Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States GABA Receptor Agonist Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of GABA Receptor Agonist Drug by Type (2013-2018)
Figure Revenue Market Share of GABA Receptor Agonist Drug by Type in 2017
Table United States GABA Receptor Agonist Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Growth Rate by Type (2013-2018)
Table United States GABA Receptor Agonist Drug Sales (K Pcs) by Application (2013-2018)
Table United States GABA Receptor Agonist Drug Sales Market Share by Application (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Market Share by Application (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Market Share by Application in 2017
Table United States GABA Receptor Agonist Drug Sales Growth Rate by Application (2013-2018)
Figure United States GABA Receptor Agonist Drug Sales Growth Rate by Application (2013-2018)
Table Advicenne Basic Information List
Table Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Advicenne GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure Advicenne GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure Advicenne GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure AstraZeneca GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table Athena Drug Delivery Solutions Basic Information List
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure Athena Drug Delivery Solutions GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table Biocodex Basic Information List
Table Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biocodex GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure Biocodex GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure Biocodex GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table Elan Corporation Basic Information List
Table Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Elan Corporation GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure Elan Corporation GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure Elan Corporation GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table H.LundBeck, Merck and Co Basic Information List
Table H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure H.LundBeck, Merck and Co GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table NovaDel Pharma Basic Information List
Table NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NovaDel Pharma GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure NovaDel Pharma GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure NovaDel Pharma GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis GABA Receptor Agonist Drug Sales Growth Rate (2013-2018)
Figure Novartis GABA Receptor Agonist Drug Sales Market Share in United States (2013-2018)
Figure Novartis GABA Receptor Agonist Drug Revenue Market Share in United States (2013-2018)
Table OVATION Pharmaceuticals Basic Information List
Table Osmotica Pharmaceutical Basic Information List
Table Pfizer Basic Information List
Table sanofi-aventis Basic Information List
Table VIVUS Basic Information List
Table XenoPort Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of GABA Receptor Agonist Drug
Figure Manufacturing Process Analysis of GABA Receptor Agonist Drug
Figure GABA Receptor Agonist Drug Industrial Chain Analysis
Table Raw Materials Sources of GABA Receptor Agonist Drug Major Players/Suppliers in 2017
Table Major Buyers of GABA Receptor Agonist Drug
Table Distributors/Traders List
Figure United States GABA Receptor Agonist Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States GABA Receptor Agonist Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States GABA Receptor Agonist Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States GABA Receptor Agonist Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States GABA Receptor Agonist Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.